SANJEEVANI AI LLC

AI Value, Measured.

St. Louis, Missouri, United States

Our product, METRIS is a SaaS platform that continuously measures where AI value is being lost and keeps that evidence current as the organization changes.

Shareable draft

Check out SANJEEVANI AI LLC on @MedStartr Today Our product, METRIS is a SaaS platform that continuously measures where AI value is being lost and keeps that evidence current as the organization changes. #DataDigitalInformationServices #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/e6PXxWP9uP4

Get Involved in SANJEEVANI AI LLC

Leadership

suneeta modekurty, MS

Primary Contact

Problem Statement

Companies are investing heavily in AI, but they cannot reliably tell whether those AI deployments are continuing to produce the business value they were supposed to produce as the organization changes.

Core Technology

The key technology is our continuous measurement and measurement-integrity engine. When something changes — such as a workflow, model, responsible team, policy, or decision authority — METRIS determines which existing measurements can still be trusted, which may have become outdated, and what needs to be measured again. This allows organizations to maintain a current evidence base rather than repeatedly starting assessments from scratch.

Key Differentiators

The core differentiator of METRIS is that it does not just monitor the AI system itself. It measures the broader operating system around an AI use case — the technology, people, workflows, organizational conditions, and business outcomes — to understand whether the AI investment is actually producing the value it was intended to produce. This is the distinction from traditional AI monitoring tools that primarily monitor models and technical performance.

Target Customers

We are initially targeting mid-market organizations that have already deployed AI into real business workflows and need to understand whether those investments are delivering the expected business value. Healthcare is an important initial market for us because of my background in healthcare, health insurance, life sciences, and clinical research. Within healthcare, we are exploring health plans, health systems, and other healthcare organizations adopting AI, while keeping the platform applicable across industries.

Product Stage

Beta

Company Info

Business Model: B2B SaaS
Founded: 2023

Technologies

Digital HealthPlatformDigital PlatformRemote MonitoringWeb-Based PlatformSoftware PlatformAI/Machine Learning

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of SANJEEVANI AI LLC?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.